Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more ...

For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety ...

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

Certain objectively measured daytime napping behaviors are associated with an increased risk for mortality for middle- to older-aged adults.

Decreases in global cognition and executive function, as well as long-term persistent declines in those cognitive domains, are associated with incident HF.

HealthDay News — Opportunities remain to increase use of the 988 Suicide and Crisis Lifeline, according to a research letter published online June 9 in JAMA Network Open.

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.

The FDA has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.

Neurosteroids demonstrate significant therapeutic promise through the modulation of the GABA system and warrant further investigation.

The Sleep Train Program improves sleep and behavior in children with both externalizing issues and sleep problems, but not in those with behavior issues alone.

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura ...

Compared with less than primary education, maternal education at the upper secondary level or higher was associated with slower rates of decline in cognitive state. HealthDay News — Parental education ...